Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries
Clémence Martin, Pierre-Régis Burgel
Eur Respir J, 58 (3) 2101487; 10.1183/13993003.01487-2021 |    |
Oxygen therapy target ranges: finding the balance
Christiaan Yu, Belinda R. Miller
Eur Respir J, 58 (3) 2101023; 10.1183/13993003.01023-2021 | |
COVID-19 pneumonia and the pulmonary vasculature: a marriage made in hell
Peter M. George, Sujal R. Desai
Eur Respir J, 58 (3) 2100811; 10.1183/13993003.00811-2021 | |
NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice
Renaud Louis, Gilles Louis, Olivier Bonhomme
Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021 | |
Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon?
Vanessa Garcia-Larsen
Eur Respir J, 58 (3) 2101386; 10.1183/13993003.01386-2021 | |
Harnessing the power of anticipation to manage respiratory-related brain suffering and ensuing dyspnoea: insights from the neurobiology of the respiratory nocebo effect
Fabien Vinckier, Sophie Betka, Nathalie Nion, Laure Serresse, Thomas Similowski
Eur Respir J, 58 (3) 2101876; 10.1183/13993003.01876-2021 | |
Dyspnoea upon hospital admission: listen to the bird of ill omen!
Maxens Decavèle, Thomas Similowski
Eur Respir J, 58 (3) 2100988; 10.1183/13993003.00988-2021 | |
Recommendations for respiratory syncytial virus surveillance at the national level
Anne C. Teirlinck, Eeva K. Broberg, Are Stuwitz Berg, Harry Campbell, Rachel M. Reeves, AnnaSara Carnahan, Bruno Lina, Gatis Pakarna, Håkon Bøås, Hanna Nohynek, Hanne-Dorthe Emborg, Harish Nair, Janine Reiche, Jesus Angel Oliva, Joanne O’Gorman, John Paget, Karol Szymanski, Kostas Danis, Maja Socan, Manuel Gijon, Marie Rapp, Martina Havlíc?ková, Ramona Trebbien, Raquel Guiomar, Siddhivinayak S. Hirve, Silke Buda, Sylvie van der Werf, Adam Meijer, Thea K. Fischer
Eur Respir J, 58 (3) 2003766; 10.1183/13993003.03766-2020 | |
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
Edward F. McKone, Cono Ariti, Abaigeal Jackson, Anna Zolin, Siobhán B. Carr, Annalisa Orenti, Jacqui G. van Rens, Lydie Lemonnier, Milan Macek, Ruth H. Keogh, Lutz Naehrlich
Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020 | |
Classification and effectiveness of different oxygenation goals in mechanically ventilated critically ill patients: network meta-analysis of randomised controlled trials
Xu Zhao, Huaping Xiao, Feng Dai, Daniel Brodie, Lingzhong Meng
Eur Respir J, 58 (3) 2002928; 10.1183/13993003.02928-2020 | |
“You can leave your mask on”: effects on cardiopulmonary parameters of different airway protective masks at rest and during maximal exercise
Massimo Mapelli, Elisabetta Salvioni, Fabiana De Martino, Irene Mattavelli, Paola Gugliandolo, Carlo Vignati, Stefania Farina, Pietro Palermo, Jeness Campodonico, Riccardo Maragna, Gerardo Lo Russo, Alice Bonomi, Susanna Sciomer, Piergiuseppe Agostoni
Eur Respir J, 58 (3) 2004473; 10.1183/13993003.04473-2020 | |
Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life
Fabio Anastasio, Sarah Barbuto, Elisa Scarnecchia, Paolo Cosma, Alessandro Fugagnoli, Giulio Rossi, Mirco Parravicini, Pierpaolo Parravicini
Eur Respir J, 58 (3) 2004015; 10.1183/13993003.04015-2020 | |
Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease
Michael F. Morris, Yash Pershad, Paul Kang, Lauren Ridenour, Ben Lavon, Maarten Lanclus, Rik Godon, Jan De Backer, Marilyn K. Glassberg
Eur Respir J, 58 (3) 2004133; 10.1183/13993003.04133-2020 | |
Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze
Hanna M. Knihtilä, Rachel S. Kelly, Nicklas Brustad, Mengna Huang, Priyadarshini Kachroo, Bo L. Chawes, Jakob Stokholm, Klaus Bønnelykke, Casper-Emil T. Pedersen, Hans Bisgaard, Augusto A. Litonjua, Jessica A. Lasky-Su, Scott T. Weiss
Eur Respir J, 58 (3) 2002012; 10.1183/13993003.02012-2020 | |
Triple therapy in uncontrolled asthma: a network meta-analysis of phase III studies
Paola Rogliani, Beatrice Ludovica Ritondo, Luigino Calzetta
Eur Respir J, 58 (3) 2004233; 10.1183/13993003.04233-2020 | |
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort
Helen K. Reddel, Jørgen Vestbo, Alvar Agustí, Gary P. Anderson, Aruna T. Bansal, Richard Beasley, Elisabeth H. Bel, Christer Janson, Barry Make, Ian D. Pavord, David Price, Eleni Rapsomaniki, Niklas Karlsson, Donna K. Finch, Javier Nuevo, Alex de Giorgio-Miller, Marianna Alacqua, Rod Hughes, Hana Müllerová, Maria Gerhardsson de Verdier
Eur Respir J, 58 (3) 2003927; 10.1183/13993003.03927-2020 | |
Intake of n-3 polyunsaturated fatty acids in childhood, FADS genotype and incident asthma
Mohammad Talaei, Emmanouela Sdona, Philip C. Calder, Louise R. Jones, Pauline M. Emmett, Raquel Granell, Anna Bergström, Erik Melén, Seif O. Shaheen
Eur Respir J, 58 (3) 2003633; 10.1183/13993003.03633-2020 | |
Expectation and dyspnoea: the neurobiological basis of respiratory nocebo effects
Elke Vlemincx, Christian Sprenger, Christian Büchel
Eur Respir J, 58 (3) 2003008; 10.1183/13993003.03008-2020 | |
Association of dyspnoea, mortality and resource use in hospitalised patients
Jennifer P. Stevens, Tenzin Dechen, Richard M. Schwartzstein, Carl R. O'Donnell, Kathy Baker, Robert B. Banzett
Eur Respir J, 58 (3) 1902107; 10.1183/13993003.02107-2019 | |
Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening
Anton Schreuder, Colin Jacobs, Nikolas Lessmann, Mireille J.M. Broeders, Mario Silva, Ivana Išgum, Pim A. de Jong, Nicola Sverzellati, Mathias Prokop, Ugo Pastorino, Cornelia M. Schaefer-Prokop, Bram van Ginneken
Eur Respir J, 58 (3) 2003386; 10.1183/13993003.03386-2020 | |
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model
Jan Heyckendorf, Sebastian Marwitz, Maja Reimann, Korkut Avsar, Andrew R. DiNardo, Gunar Günther, Michael Hoelscher, Elmira Ibraim, Barbara Kalsdorf, Stefan H.E. Kaufmann, Irina Kontsevaya, Frank van Leth, Anna M. Mandalakas, Florian P. Maurer, Marius Müller, Dörte Nitschkowski, Ioana D. Olaru, Cristina Popa, Andrea Rachow, Thierry Rolling, Jan Rybniker, Helmut J.F. Salzer, Patricia Sanchez-Carballo, Maren Schuhmann, Dagmar Schaub, Victor Spinu, Isabelle Suárez, Elena Terhalle, Markus Unnewehr, January Weiner, Torsten Goldmann, Christoph Lange
Eur Respir J, 58 (3) 2003492; 10.1183/13993003.03492-2020 | |
The pathophysiological role of novel pulmonary arterial hypertension gene SOX17
Yukyee Wu, John Wharton, Rachel Walters, Eleni Vasilaki, Jurjan Aman, Lan Zhao, Martin R. Wilkins, Christopher J. Rhodes
Eur Respir J, 58 (3) 2004172; 10.1183/13993003.04172-2020 | |
Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Colin E. Evans, Nicholas D. Cober, Zhiyu Dai, Duncan J. Stewart, You-Yang Zhao
Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020 | |
Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe
Antoni Noguera-Julian, Danilo Buonsenso, Lindsay McKenna, James A. Seddon, Nicole Ritz
Eur Respir J, 58 (3) 2101196; 10.1183/13993003.01196-2021 | |
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial
Mona Bafadhel, Neil Barnes, Stephen C. Bourke, Chris Compton, Gerard J. Criner, Mark T. Dransfield, David M.G. Halpin, MeiLan K. Han, Benjamin Hartley, C. Elaine Jones, Peter Lange, Sally Lettis, David A. Lipson, David A. Lomas, Neil Martin, Fernando J. Martinez, Robert Wise, Dave Singh
Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020 | |
Five-year survival after an acute episode of decompensated pulmonary arterial hypertension in the modern management era of right heart failure
Laurent Savale, Constance Vuillard, Jérémie Pichon, Athénaïs Boucly, Anne Roche, Mitja Jevnikar, Nathan Ebstein, Xavier Jaïs, Jérôme Le Pavec, David Montani, Olaf Mercier, Olivier Sitbon, Elie Fadel, Marc Humbert
Eur Respir J, 58 (3) 2100466; 10.1183/13993003.00466-2021 | |
COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol
Stefan J. Marciniak, James Farrell, Anthony Rostron, Ian Smith, Peter J.M. Openshaw, J. Kenneth Baillie, Annemarie Docherty, Malcolm G. Semple
Eur Respir J, 58 (3) 2100929; 10.1183/13993003.00929-2021 | |
Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems
Simone Villa, Elisa Tagliani, Emanuele Borroni, Paola Francesca Castellotti, Maurizio Ferrarese, Arash Ghodousi, Anna Lamberti, Sabrina Senatore, Marino Faccini, Daniela Maria Cirillo, Luigi Ruffo Codecasa
Eur Respir J, 58 (3) 2100839; 10.1183/13993003.00839-2021 | |
Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown
Armand Van Deun, Tom Decroo, Kya Jai Maug Aung, Mohamed Anwar Hossain, Mourad Gumusboga, Willem Bram De Rijk, Sabira Tahseen, Bouke Catherine de Jong, Leen Rigouts
Eur Respir J, 58 (3) 2100783; 10.1183/13993003.00783-2021 | |
Protective face masks add significant dead space
Christoph Elbl, Josef X. Brunner, Dominic Schier, Adrian Junge, Helge Junge
Eur Respir J, 58 (3) 2101131; 10.1183/13993003.01131-2021 | |
When adopting Global Lung Function Initiative reference values, can we also adapt them to a local context as needed?
Sylvia Verbanck, Eef Vanderhelst, Shane Hanon
Eur Respir J, 58 (3) 2101601; 10.1183/13993003.01601-2021 | |
Reply to: When adopting Global Lung Function Initiative reference values, can we also adapt them to a local context as needed?
Sanja Stanojevic, Brendan Cooper, Nicole Filipow, Jane Kirkby, Gregg Ruppel, Irene Steenbruggen, Bruce Thompson, Graham Hall
Eur Respir J, 58 (3) 2102020; 10.1183/13993003.02020-2021 | |
When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
Job F.M. van Boven, Boudewijn J.H. Dierick, Omar S. Usmani
Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021 | |
Considerations of a real life pragmatic clinical trial in adolescent asthma
Tom Ruffles, Brian Lipworth, Somnath Mukhopadhyay
Eur Respir J, 58 (3) 2100461; 10.1183/13993003.00461-2021 | |
miR-184 mediates hyperoxia-induced injury by targeting cell death and angiogenesis signalling pathways in the developing lung
Dilip Shah, Karmyodh Sandhu, Pragnya Das, Zubair H. Aghai, Sture Andersson, Gloria Pryhuber, Vineet Bhandari
Eur Respir J, 58 (3) 1901789; 10.1183/13993003.01789-2019 | |